These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13878777)

  • 41. [Experimental studies on the properdin system of the rabbit. (III). On changes in the properdin titer under varying conditions].
    YAMAMASU N
    Nihon Saikingaku Zasshi; 1961 Oct; 16():873-6. PubMed ID: 14008819
    [No Abstract]   [Full Text] [Related]  

  • 42. [The properdin level in neoplasms and in malignant blood diseases].
    DIOMEDE-FRESA V; FUMAROLA A
    Prog Med (Napoli); 1959 May; 15():310-4. PubMed ID: 13816890
    [No Abstract]   [Full Text] [Related]  

  • 43. Investigation of the serum properdin levels in neoplastic diseases determined by the bacteriophage neutralization assay.
    SEKIGUCHI M; ASHIKAWA K; MOTOYA K; ISHIBASHI Y
    Gan; 1962 Jun; 53():129-43. PubMed ID: 13910377
    [No Abstract]   [Full Text] [Related]  

  • 44. [The "properdin system" and some stomatologic affections. XI. The behavior of the serum properdin level in patients with malignant neoplasms of the oral cavity, after treatment with yeast-therapy].
    NITTI G
    Boll Soc Ital Biol Sper; 1962 Sep; 38():850-2. PubMed ID: 13938846
    [No Abstract]   [Full Text] [Related]  

  • 45. [Properdin system & antibody formation. II. Blood properdin picture of rabbits during immunization with Salmonella typhosa].
    WAHLIG H
    Arch Mikrobiol; 1959; 32(4):322-7. PubMed ID: 13650571
    [No Abstract]   [Full Text] [Related]  

  • 46. The properdin system and immunity. X. Characterization of partially purified human properdin.
    LEPOW IH; PILLEMER L; SCHOENBERG MD; TODD EW; WEDGWOOD RJ
    J Immunol; 1959 Oct; 83():428-36. PubMed ID: 14415902
    [No Abstract]   [Full Text] [Related]  

  • 47. [The properdin system and antibody formation. I. The serum properdin level in rabbits during immunization with Mycobacterium tuberculosis].
    WAHLIG H
    Arch Mikrobiol; 1959; 32(2):127-37. PubMed ID: 13628083
    [No Abstract]   [Full Text] [Related]  

  • 48. [The activity of the properdin system in burns].
    MURAZIAN RI; CHERTKOV IL
    Khirurgiia (Mosk); 1960 May; 36():77-81. PubMed ID: 14425332
    [No Abstract]   [Full Text] [Related]  

  • 49. [Anticomplement activity of a polyanion: pentosan sulfuric polyester. III. Mechanism of functional inactivation of the different properdin and complement system fractions].
    Berthoux FC; Freyria AM; Traeger J
    Pathol Biol (Paris); 1977 Mar; 25(3):179-84. PubMed ID: 323787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
    Vogt W; Schmidt G; Lynen R; Dieminger L
    J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Partial properdin deficiency revealed by a septicemia caused by Neisseria meningitidis].
    Frémeaux-Bacchi V; Le Coustumier A; Blouin J; Kazatchkine MD; Weiss L
    Presse Med; 1995 Sep; 24(28):1305-7. PubMed ID: 7501623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells.
    Schwaeble W; Dippold WG; Schäfer MK; Pohla H; Jonas D; Luttig B; Weihe E; Huemer HP; Dierich MP; Reid KB
    J Immunol; 1993 Sep; 151(5):2521-8. PubMed ID: 8360474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
    BLUM L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
    [No Abstract]   [Full Text] [Related]  

  • 54. Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin.
    Götze O; Medicus RG; Müller-Eberhard HJ
    J Immunol; 1977 Feb; 118(2):525-32. PubMed ID: 839069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The "properdin system" and some stomatologic affections. IX. Relation between the serum properdin level and some forms of benign neoplasms of the oral cavity].
    PETTINI PL
    Boll Soc Ital Biol Sper; 1962 Sep; 38():833-4. PubMed ID: 13942987
    [No Abstract]   [Full Text] [Related]  

  • 56. The properdin system and immunity. XII. Assay, properties and partial purification of a hydrazine-sensitive serum factor (factor A) in the properdin system.
    PENSKY J; WURZ L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():329-48. PubMed ID: 14431638
    [No Abstract]   [Full Text] [Related]  

  • 57. [Properdin system: properdin level in children].
    FUMAROLA D
    Boll Ist Sieroter Milan; 1958; 37(1-2):87-91. PubMed ID: 13536005
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the study of the properdin system. I. A simplified method for the determination of properdin].
    ROZENTAL' KM ; SAVEL'VOL'F GB
    Biull Eksp Biol Med; 1959 Nov; 48():122-6. PubMed ID: 13856311
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies of the inactivation of phage by the properdin system. I. Evidence for complement, properdin and magnesium requirements.
    BARLOW JL; VAN VUNAKIS H; LEVINE L
    J Immunol; 1958 May; 80(5):339-48. PubMed ID: 13539378
    [No Abstract]   [Full Text] [Related]  

  • 60. The properdin system and immunity. IX. Studies on the purification of human properdin.
    TODD EW; PILLEMER L; LEPOW IH
    J Immunol; 1959 Oct; 83():418-27. PubMed ID: 13838615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.